Baird raised the firm’s price target on Labcorp (LH) to $267 from $253 and keeps an Outperform rating on the shares. The firm updated its model following Q1 results.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Labcorp price target raised to $250 from $240 at Barclays
- Labcorp’s Resilience and Growth Potential: A Reliable Investment Choice Despite Revenue Miss
- Labcorp Holdings: Strong Q1 2025 Performance and Positive Outlook Justify Buy Rating
- Labcorp Reports Q1 2025 Earnings and Strategic Growth
- Labcorp’s Earnings Call Highlights Growth and Innovation